Follow
Clinical Research
Clinical Research: Patient - oriented research. Clinical research is a branch of healthcare science that determines the safety and effectiveness (efficacy) of medications, devices, diagnostic products and treatment regimens intended for human use. These may be used for prevention, treatment, diagnosis or for relieving symptoms of a disease.
-
OCT 01, 2015 | 10:30 AM
The assessment of pigmented lesions is a difficult area of dermatology and dermatopathology. Melanoma is the leading cause of cancer in woman age 25-29 years, yet it is also a leading c...Speaker: Whitney High, MD, JD, M.EngOCT 01, 2015 | 9:30 AM
Background: The extracellular vesicle (EV) research field has dramatically increased in the last five years. Using a high-speed flow cytometric sorter, EVs may be isolated at high...Speaker: Carley Ross, PhDPresented at: Beckman Coulter Life Sciences Virtual Trade Show
Sponsored By: Beckman Coulter Life Sciences, Beckman Coulter Life SciencesOCT 01, 2015 | 9:00 AM
Of special interest in a clinical setting is the identification and interpretation of somatic variants from the DNA of a tumor/normal matched pair. Studies have shown that a large proportion...Speaker: Anika Joecker, PhDOCT 01, 2015 | 8:00 AM
Is your lab constantly challenged by case back log while trying to validate new methods to identify designer drugs? Your challenge is common to many forensic toxicology labs around the world....Speaker: Maciej Bromirski, MSc , Kristine Van NattaSponsored By: Thermo Fisher Scientific, Thermo Fisher ScientificOCT 01, 2015 | 7:30 AM
Melanoma, a cancer of pigment-producing cells, accounts for nearly 200,000 new cases of cancer reported each year worldwide. It is the deadliest skin cancer. Alarmingly, in the U.S., the inci...Speaker: Louise Perkins, PhDOCT 01, 2015 | 7:30 AM
While TDM is routinely used in a number of medical fields, it has not gained wide utilization in oncology. There is a growing body of evidence demonstrating that current dosing methods based...Speaker: Salvatore Salamone, PhDSEP 30, 2015 | 1:30 PM
Endometrial adenoarcinoma is a common cause of gynecological cancer death in Europe and North America. The most dominant subtype, Endometrioid Endometrial Cancer (EEC) accounts for >80% of...Speaker: Jean-Noel Billaud, PhDSEP 30, 2015 | 1:30 PM
A major goal of molecular diagnostics is to find a sensitive and specific means for detecting and quantifying DNA fragments from rare cancer cells (by virtue of an identifying somatic mutatio...SEP 30, 2015 | 1:30 PM
Biomarkers, with their associated “tsunami” of publications, represent what is arguably one of the largest areas of scientific inquiry in the history of biomedicine. Touted as the...SEP 30, 2015 | 12:00 PM
This presentation discusses the advantages and disadvantages of robotic surgery. The initial goals for a robotic prostatectomy will be discussed as well as patient expectations and outcomes.&...Speaker: David Albala, MD , Herbert Lepor, MDSEP 30, 2015 | 10:30 AM
Micro RNAs (miRNAs) are small, naturally-occurring non-coding ribonucleic acids with sizes between 18 and 40 nucleotides (nts) that have been demonstrated to play a significant role in the re...Speaker: Bee Na Lee, PhDPresented at: Beckman Coulter Life Sciences Virtual Trade Show
Sponsored By: Beckman Coulter Life SciencesSEP 30, 2015 | 10:30 AM
The management of prostate cancer (PCa) continues to evolve and does so at a rapid rate. Research and technological developments continue to refine our definitions and management of this comp...Speaker: Rajan Gupta, MD , Thomas Polascik, MD , Stacy Loeb, MDSEP 30, 2015 | 9:00 AM
The burgeoning area of molecular risk assessment (gene expression profiling and/or proteomic tests) in the diagnosis and treatment of prostate cancer is rapidly illuminating how clinicians mi...SEP 30, 2015 | 7:30 AM
The landscape for treatment options in metastatic castration resistant prostate cancer has changed dramatically since 2010. There have been more therapies approved since 2010 than in the prio...Speaker: Lawrence Karsh MD FACSSEP 30, 2015 | 7:30 AM
We have been developing methods to target drugs specifically to pathologic cells, thereby avoiding collateral toxicity to healthy cells. In the case of cancer, we have exploited up-regulation...SEP 22, 2015 | 9:00 AM
DATE: Sept 22, 2015TIME: 9:00am PDT, 12:00PM EDTHeart failure is a complex syndrome and affects over 5.1 Million Americans today with approximately 500,000 new heart failure cases each year. ...Speaker: Peter McCullough, M.D., M.P.H. F.A.C.P., F.A.C.C., F.C.C.P., F.A.H.A., F.N.K.F., F.N.L.A., F.C.R.S.A.Sponsored By: Abbott Molecular Diagnostic, Abbott Molecular DiagnosticSEP 16, 2015 | 2:00 PM
Synthetic biology—the design and construction of new biological parts, devices, and systems, and the redesign of natural biological systems for useful purposes—is contributing sus...Speaker: Nancy KelleySEP 16, 2015 | 12:00 PM
Nanotechnology, the engineering and manufacture of materials at the atomic and molecular scale, is used at BIND Therapeutics to develop novel Accurin™ nanomedicines that utilize cytotoxic age...Speaker: Hagop YoussoufianSEP 16, 2015 | 9:00 AM
Learning Objectives for this presentation - (1) Understand how human genetics can contribute to drug discovery and development. (2) Understand the role of biomarkers and clinical proof-...Speaker: Robert PlengeSEP 15, 2015 | 10:00 AM
DATE: September 15, 2015TIME: 10:00AM Pacific time, 1:00PM Eastern timeThe breadth of instruments available for quantitative PCR (qPCR) has continued to grow in the past 5-10 years. With ...SEP 15, 2015 | 8:00 AM
Chromosomal microarray analysis (CMA) is an established technology, which has demonstrated great sensitivity and specificity for detecting genome-wide copy number variants (CNVs). CMA represe...SEP 15, 2015 | 7:00 AM
Cellular viability is usually determined by measuring the capacity of cells to exclude vital dyes such as 4',6-diamidino-2-phenylindole (DAPI), or by assessing nuclear morphology with chr...Speaker: Oliver Kepp, PhD , Allan SauvatPresented at: Beckman Coulter Life Sciences Virtual Trade Show
Sponsored By: Beckman Coulter Life Sciences, Beckman Coulter Life SciencesSEP 10, 2015 | 4:00 AM
The webinar will start at 4am Pacific Time, 7am Eastern Time, 1pm Central European Summer Time, 7pm China Standard Time Extracellular vesicles (EVs) including exosome and microvesi...Speaker: Charles Lai, PhDPresented at: Beckman Coulter Life Sciences Virtual Trade Show
Sponsored By: Beckman Coulter Life Sciences, Beckman Coulter Life SciencesSEP 09, 2015 | 9:00 AM
DATE: September 9, 2015TIME: 9:00am PDT, 12:00PM EDTDriver mutations are causally implicated in tumorigenesis and disease progression, and they are defined by molecular abnormalities such as ...
OCT 01, 2015 | 10:30 AM
The assessment of pigmented lesions is a difficult area of dermatology and dermatopathology. Melanoma is the leading cause of cancer in woman age 25-29 years, yet it is also a leading c...
Speaker:
Whitney High, MD, JD, M.Eng
OCT 01, 2015 | 9:30 AM
Background: The extracellular vesicle (EV) research field has dramatically increased in the last five years. Using a high-speed flow cytometric sorter, EVs may be isolated at high...
Speaker:
Carley Ross, PhD
Presented at: Beckman Coulter Life Sciences Virtual Trade Show
Sponsored By: Beckman Coulter Life Sciences, Beckman Coulter Life Sciences
Sponsored By: Beckman Coulter Life Sciences, Beckman Coulter Life Sciences
OCT 01, 2015 | 9:00 AM
Of special interest in a clinical setting is the identification and interpretation of somatic variants from the DNA of a tumor/normal matched pair. Studies have shown that a large proportion...
Speaker:
Anika Joecker, PhD
OCT 01, 2015 | 8:00 AM
Is your lab constantly challenged by case back log while trying to validate new methods to identify designer drugs? Your challenge is common to many forensic toxicology labs around the world....
Speaker:
Maciej Bromirski, MSc
, Kristine Van Natta
Sponsored By: Thermo Fisher Scientific,
Thermo Fisher Scientific
OCT 01, 2015 | 7:30 AM
Melanoma, a cancer of pigment-producing cells, accounts for nearly 200,000 new cases of cancer reported each year worldwide. It is the deadliest skin cancer. Alarmingly, in the U.S., the inci...
Speaker:
Louise Perkins, PhD
OCT 01, 2015 | 7:30 AM
While TDM is routinely used in a number of medical fields, it has not gained wide utilization in oncology. There is a growing body of evidence demonstrating that current dosing methods based...
Speaker:
Salvatore Salamone, PhD
SEP 30, 2015 | 1:30 PM
Endometrial adenoarcinoma is a common cause of gynecological cancer death in Europe and North America. The most dominant subtype, Endometrioid Endometrial Cancer (EEC) accounts for >80% of...
Speaker:
Jean-Noel Billaud, PhD
SEP 30, 2015 | 1:30 PM
A major goal of molecular diagnostics is to find a sensitive and specific means for detecting and quantifying DNA fragments from rare cancer cells (by virtue of an identifying somatic mutatio...
SEP 30, 2015 | 1:30 PM
Biomarkers, with their associated “tsunami” of publications, represent what is arguably one of the largest areas of scientific inquiry in the history of biomedicine. Touted as the...
SEP 30, 2015 | 12:00 PM
This presentation discusses the advantages and disadvantages of robotic surgery. The initial goals for a robotic prostatectomy will be discussed as well as patient expectations and outcomes.&...
Speaker:
David Albala, MD
, Herbert Lepor, MD
SEP 30, 2015 | 10:30 AM
Micro RNAs (miRNAs) are small, naturally-occurring non-coding ribonucleic acids with sizes between 18 and 40 nucleotides (nts) that have been demonstrated to play a significant role in the re...
Speaker:
Bee Na Lee, PhD
Presented at: Beckman Coulter Life Sciences Virtual Trade Show
Sponsored By: Beckman Coulter Life Sciences
Sponsored By: Beckman Coulter Life Sciences
SEP 30, 2015 | 10:30 AM
The management of prostate cancer (PCa) continues to evolve and does so at a rapid rate. Research and technological developments continue to refine our definitions and management of this comp...
Speaker:
Rajan Gupta, MD
, Thomas Polascik, MD
, Stacy Loeb, MD
SEP 30, 2015 | 9:00 AM
The burgeoning area of molecular risk assessment (gene expression profiling and/or proteomic tests) in the diagnosis and treatment of prostate cancer is rapidly illuminating how clinicians mi...
SEP 30, 2015 | 7:30 AM
The landscape for treatment options in metastatic castration resistant prostate cancer has changed dramatically since 2010. There have been more therapies approved since 2010 than in the prio...
Speaker:
Lawrence Karsh MD FACS
SEP 30, 2015 | 7:30 AM
We have been developing methods to target drugs specifically to pathologic cells, thereby avoiding collateral toxicity to healthy cells. In the case of cancer, we have exploited up-regulation...
SEP 22, 2015 | 9:00 AM
DATE: Sept 22, 2015TIME: 9:00am PDT, 12:00PM EDTHeart failure is a complex syndrome and affects over 5.1 Million Americans today with approximately 500,000 new heart failure cases each year. ...
Speaker:
Peter McCullough, M.D., M.P.H. F.A.C.P., F.A.C.C., F.C.C.P., F.A.H.A., F.N.K.F., F.N.L.A., F.C.R.S.A.
Sponsored By: Abbott Molecular Diagnostic,
Abbott Molecular Diagnostic
SEP 16, 2015 | 2:00 PM
Synthetic biology—the design and construction of new biological parts, devices, and systems, and the redesign of natural biological systems for useful purposes—is contributing sus...
Speaker:
Nancy Kelley
SEP 16, 2015 | 12:00 PM
Nanotechnology, the engineering and manufacture of materials at the atomic and molecular scale, is used at BIND Therapeutics to develop novel Accurin™ nanomedicines that utilize cytotoxic age...
Speaker:
Hagop Youssoufian
SEP 16, 2015 | 9:00 AM
Learning Objectives for this presentation -
(1) Understand how human genetics can contribute to drug discovery and development.
(2) Understand the role of biomarkers and clinical proof-...
Speaker:
Robert Plenge
SEP 15, 2015 | 10:00 AM
DATE: September 15, 2015TIME: 10:00AM Pacific time, 1:00PM Eastern timeThe breadth of instruments available for quantitative PCR (qPCR) has continued to grow in the past 5-10 years. With ...
SEP 15, 2015 | 8:00 AM
Chromosomal microarray analysis (CMA) is an established technology, which has demonstrated great sensitivity and specificity for detecting genome-wide copy number variants (CNVs). CMA represe...
SEP 15, 2015 | 7:00 AM
Cellular viability is usually determined by measuring the capacity of cells to exclude vital dyes such as 4',6-diamidino-2-phenylindole (DAPI), or by assessing nuclear morphology with chr...
Speaker:
Oliver Kepp, PhD
, Allan Sauvat
Presented at: Beckman Coulter Life Sciences Virtual Trade Show
Sponsored By: Beckman Coulter Life Sciences, Beckman Coulter Life Sciences
Sponsored By: Beckman Coulter Life Sciences, Beckman Coulter Life Sciences
SEP 10, 2015 | 4:00 AM
The webinar will start at 4am Pacific Time, 7am Eastern Time, 1pm Central European Summer Time, 7pm China Standard Time
Extracellular vesicles (EVs) including exosome and microvesi...
Speaker:
Charles Lai, PhD
Presented at: Beckman Coulter Life Sciences Virtual Trade Show
Sponsored By: Beckman Coulter Life Sciences, Beckman Coulter Life Sciences
Sponsored By: Beckman Coulter Life Sciences, Beckman Coulter Life Sciences
SEP 09, 2015 | 9:00 AM
DATE: September 9, 2015TIME: 9:00am PDT, 12:00PM EDTDriver mutations are causally implicated in tumorigenesis and disease progression, and they are defined by molecular abnormalities such as ...